Takayuki Mizutani
Direktor/Vorstandsmitglied bei Theoria Science KK
Aktive Positionen von Takayuki Mizutani
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Theoria Science KK
 Theoria Science KK BiotechnologyHealth Technology Theoria Science KK is a company founded in 2012 and based in Tokyo, Japan. The Japanese company specializes in exosome research and offers the latest clinical knowledge and expertise in the field. Theoria Science is focused on developing early detection methods and therapeutic drugs for various diseases, including blood cancer. The company also provides medical services related to exosome research, such as early risk detection tests. | Direktor/Vorstandsmitglied | 01.01.2014 | - |
Karriereverlauf von Takayuki Mizutani
Ehemalige bekannte Positionen von Takayuki Mizutani
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
B-Bridge International, Inc.
 B-Bridge International, Inc. BiotechnologyHealth Technology B-Bridge International, Inc. manufactures biological products. It offers antibodies synthetic substitutes, cells, general reagents, IHC staining reagents, instruments, and kinase inhibitors. The company was founded by Hiroyuki Masumoto in 2000 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Takayuki Mizutani
| California State University-Chico | Graduate Degree |
| The Ohio State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Japan | 2 |
Operativ
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
B-Bridge International, Inc.
B-Bridge International, Inc. BiotechnologyHealth Technology B-Bridge International, Inc. manufactures biological products. It offers antibodies synthetic substitutes, cells, general reagents, IHC staining reagents, instruments, and kinase inhibitors. The company was founded by Hiroyuki Masumoto in 2000 and is headquartered in Santa Clara, CA. | Health Technology |
Theoria Science KK
Theoria Science KK BiotechnologyHealth Technology Theoria Science KK is a company founded in 2012 and based in Tokyo, Japan. The Japanese company specializes in exosome research and offers the latest clinical knowledge and expertise in the field. Theoria Science is focused on developing early detection methods and therapeutic drugs for various diseases, including blood cancer. The company also provides medical services related to exosome research, such as early risk detection tests. | Health Technology |
- Börse
- Insiders
- Takayuki Mizutani
- Erfahrung
